Table 2 Patients receiving anal/rectal pap tests between January 2006–March 2018
|  | Ever received (N = 1648) | Never received (N = 2834) | P-value |
|---|---|---|---|
Gender | |||
 Men | 1611 (47.0) | 1816 (53.0) | < 0.0001 |
 Women | 16 (1.5) | 1015 (98.5) |  |
 Transgender M-F | 21 (87.5) | 3 (12.5) |  |
Race | |||
 Black | 836 (31.3) | 1839 (68.7) | < 0.0001 |
 White | 764 (46.8) | 867 (53.2) |  |
 Others | 48 (27.3) | 128 (72.7) |  |
Self-reported sexual risk factors | N = 1591 | N = 2683 |  |
 MSM | 1504 (61.7) | 932 (38.3) | < 0.0001 |
 Heterosexual men | 72 (8.4) | 781 (91.6) |  |
 Heterosexual women | 15 (1.5) | 970 (98.5) |  |
Anal HSIL and cancer | |||
 HSIL | 56 (70.9) | 23 (29.1) | < 0.0001 |
 Cancer | 19 (55.8) | 24 (44.2) |  |
Race- sexual behavior | N = 1591 | N = 2683 |  |
 Black MSM | 732 (62.3) | 442 (37.7) | < 0.0001 |
 Black heterosexual men | 51 (8.1) | 578 (91.1) |  |
 Black heterosexual women | 10 (1.4) | 731 (98.6) |  |
 White MSM | 729 (62.0) | 446 (38.0) |  |
 White heterosexual men | 19 (10.6) | 161 (89.4) |  |
 White heterosexual women | 5 (2.3) | 213 (97.7) |  |
 Other race MSM | 43 (49.4) | 44 (50.6) |  |
 Other race heterosexual men | 2 (4.6) | 42 (95.4) |  |
 Other race heterosexual women | 0 (0) | 26 (100) |  |